Related Experiment Videos
Identifying and testing for hereditary susceptibility to common cancers
Randa Sifri1, Sarita Gangadharappa, Louise S Acheson
1Department of Family Medicine, Thomas Jefferson University, Philadelphia, PA, USA.
CA: a Cancer Journal for Clinicians
|November 13, 2004
Summary
Hereditary cancer syndromes, like those for breast, ovarian, and colon cancer, are increasingly recognized. Understanding genetic risk assessment is crucial for healthcare providers to identify and counsel at-risk patients.
Area of Science:
- Oncology
- Genetics
- Preventive Medicine
Background:
- Hereditary cancer syndromes contribute to approximately 5% of breast, ovarian, and colon cancers.
- Advances in gene discovery have significantly improved cancer genetic risk assessment.
- Growing patient awareness necessitates healthcare professional education on hereditary cancer syndromes.
Purpose of the Study:
- To outline the essential components of hereditary cancer risk assessment.
- To focus on hereditary breast and ovarian cancer syndrome and hereditary colon cancer.
- To equip health professionals with knowledge for identifying and advising at-risk patients.
Main Methods:
- Review of current literature on hereditary cancer syndromes.
- Synthesis of key elements in genetic risk assessment protocols.
- Case study examples for hereditary breast, ovarian, and colon cancer syndromes.
Main Results:
- Identification of key genetic markers and risk factors for hereditary breast, ovarian, and colon cancers.
- Established guidelines for patient screening and genetic testing.
- Framework for effective patient counseling and management strategies.
Conclusions:
- Hereditary cancer risk assessment is vital for early detection and prevention.
- Healthcare providers must be knowledgeable in genetic risk assessment for common hereditary cancer syndromes.
- Comprehensive assessment and counseling improve outcomes for patients with hereditary cancer syndromes.